Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients (ITX5061)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01292824
Recruitment Status : Completed
First Posted : February 10, 2011
Last Update Posted : December 3, 2015
University Hospital Birmingham
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
University of Birmingham